Return of genetic results in the familial dilated cardiomyopathy research project

Journal of Genetic Counseling

Volumn 22, Issue 2, 2013, Pages 164-174

  Siegfried, Jill D ^a,f   Morales, Ana ^a   Kushner, Jessica D ^b   Burkett, Emily ^c   Cowan, Jason ^d   Mauro, Ana Clara ^a   Huggins, Gordon S ^e   Li, Duanxiang ^a   Norton, Nadine ^a   Hershberger, Ray E ^a,g  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Maternal Fetal Medicine   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f AMBRY GENETICS   (United States)

^g OHIO STATE UNIVERSITY   (United States)

Author keywords

Dilated cardiomyopathy; Family studies; Genetic counseling; Genetics; Return of results

Indexed keywords

ARTICLE; CONGESTIVE CARDIOMYOPATHY; FAMILIAL DILATED CARDIOMYOPATHY; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HUMAN; UNITED STATES;

CARDIOMYOPATHY, DILATED; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; UNITED STATES;

EID: 84879693681     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-012-9532-8     Document Type: Article

References (40)

1. Ackerman, M. J.; Priori, S. G.; Willems, S.; Berul, C.; Brugada, R.; Calkins, H.; et al. (2011). HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies This document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm, 8(8), 1308-1339.
2. Bookman, E. B.; Langehorne, A. A.; Eckfeldt, J. H.; Glass, K. C.; Jarvik, G. P.; Klag, M.; et al. (2006). Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. American Journal of Medical Genetics. Part A, 140(10), 1033-1040.
3. Burkett, E. L.; & Hershberger, R. E. (2005). Clinical and genetic issues in familial dilated cardiomyopathy. Journal of the American College of Cardiology, 45(7), 969-981.
4. Caleshu, C.; Day, S.; Rehm, H. L.; & Baxter, S. (2010). Use and interpretation of genetic tests in cardiovascular genetics. Heart, 96(20), 1669-1675.
5. Cheng, J.; Morales, A.; Siegfried, J. D.; Li, D.; Norton, N.; Song, J.; et al. (2010). SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and splice variant Q1077del. Clin Trans Sci, 3, 287-294.
6. Cowan, J.; Li, D.; Gonzalez-Quintana, J.; Morales, A.; & Hershberger, R. E. (2010). Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Circulation. Cardiovascular Genetics, 3(1), 6-14.
7. Crispell, K. A.; Wray, A.; Ni, H.; Nauman, D. J.; & Hershberger, R. E. (1999). Clinical profiles of four large pedigrees with familial dilated cardiomyopathy: preliminary recommendations for clinical practice. Journal of the American College of Cardiology, 34(3), 837-847.
8. Das, S.; Bale, S. J.; & Ledbetter, D. H. (2008). Molecular genetic testing for ultra rare diseases: models for translation from the research laboratory to the CLIA-certified diagnostic laboratory. Genetics in Medicine, 10(5), 332-336.
9. Fabsitz, R. R.; McGuire, A.; Sharp, R. R.; Puggal, M.; Beskow, L. M.; Biesecker, L. G.; et al. (2010). Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Circulation. Cardiovascular Genetics, 3(6), 574-580.
10. Fatkin, D.; MacRae, C.; Sasaki, T.; Wolff, M.; Porcu, M.; Frenneaux, M.; et al. (1999). Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. The New England Journal of Medicine, 341(23), 1715-1724.
11. Gollob, M. H.; Blier, L.; Brugada, R.; Champagne, J.; Chauhan, V.; Connors, S.; et al. (2011). Recommendations for the use of genetic testing in the clinical evaluation of inherited cardiac arrhythmias associated with sudden cardiac death: Canadian Cardiovascular Society/Canadian Heart Rhythm Society joint position paper. Canadian Journal of Cardiology, 27(2), 232-245.
12. Hanson, E.; & Hershberger, R. E. (2001). Genetic counseling and screening issues in familial dilated cardiomyopathy. Journal of Genetic Counseling, 10(5), 397-415.
13. Hanson, E.; Jakobs, P.; Keegan, H.; Coates, K.; Bousman, S.; Dienel, N.; et al. (2002). Cardiac troponin T lysine-210 deletion in a family with dilated cardiomyopathy. Journal of Cardiac Failure, 8, 28-32.
14. Hayden, E. C. (2011). Secrets of the human genome disclosed. Nature, 478(7367), 17.
15. Hershberger, R. E.; & Siegfried, J. D. (2011). State of the Art Review. Update 2011: clinical and genetic issues in familial dilated cardiomyopathy. Journal of the American College of Cardiology, 57(16), 1641-1649.
16. Hershberger, R. E.; Hanson, E.; Jakobs, P. M.; Keegan, H.; Coates, K.; Bousman, S.; et al. (2002). A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. American Heart Journal, 144(6), 1081-1086.
17. Hershberger, R. E.; Cowan, J.; & Morales, A. (2008a). LMNA-related dilated cardiomyopathy. http://www.genetests.org.
18. Hershberger, R. E.; Parks, S. B.; Kushner, J. D.; Li, D.; Ludwigsen, S.; Jakobs, P.; et al. (2008b). Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clinical Translational Science, 1(1), 21-26.
19. Hershberger, R. E.; Cowan, J.; Morales, A.; & Siegfried, J. D. (2009a). Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation. Heart Failure, 2(3), 253-261.
20. Hershberger, R. E.; Lindenfeld, J.; Mestroni, L.; Seidman, C. E.; Taylor, M. R.; & Towbin, J. A. (2009b). Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. Journal of Cardiac Failure, 15(2), 83-97.
21. Hershberger, R. E.; Pinto, J. R.; Parks, S. B.; Kushner, J. D.; Li, D.; Ludwigsen, S.; et al. (2009c). Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circulation. Cardiovascular Genetics, 2(4), 306-313.
22. Hershberger, R. E.; Morales, A.; & Siegfried, J. D. (2010a). Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals. Genetics in Medicine, 12(11), 655-667.
23. Hershberger, R. E.; Norton, N.; Morales, A.; Li, D.; Siegfried, J. D.; & Gonzalez-Quintana, J. (2010b). Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circulation. Cardiovascular Genetics, 3(2), 155-161.
24. Ho, C. Y.; & MacRae, C. A. (2009). Defining the pathogenicity of DNA sequence variation. Circulation. Cardiovascular Genetics, 2(2), 95-97.
25. Jakobs, P. M.; Hanson, E.; Crispell, K. A.; Toy, W.; Keegan, H.; Schilling, K.; et al. (2001). Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. Journal of Cardiac Failure, 7(3), 249-256.
26. Kaufman, D.; Murphy, J.; Scott, J.; & Hudson, K. (2008). Subjects matter: a survey of public opinions about a large genetic cohort study. Genetics in Medicine, 10(11), 831-839.
27. Kushner, J. D.; Nauman, D.; Burgess, D.; Ludwigsen, S.; Parks, S.; Pantely, G.; et al. (2006). Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy. Journal of Cardiac Failure, 12(6), 422-429.
28. Ledbetter, D. H.; & Faucett, W. A. (2008). Issues in genetic testing for ultra-rare diseases: background and introduction. Genetics in Medicine, 10(5), 309-313.
29. Li, D.; Morales, A.; Gonzalez Quintana, J.; Norton, N.; Siegfried, J. D.; Hofmeyer, M.; et al. (2010). Identification of novel mutations In RBM20 in patients with dilated cardiomyopathy. Clin Trans Sci, 3(3), 90-97.
30. Meulenkamp, T. M.; Gevers, S. J.; Bovenberg, J. A.; & Smets, E. M. (2011). Researchers' opinions towards the communication of results of biobank research: a survey study. European Journal of Human Genetics.
31. Miller, F. A.; Hayeems, R. Z.; & Bytautas, J. P. (2010). What is a meaningful result? Disclosing the results of genomic research in autism to research participants. European Journal of Human Genetics, 18(8), 867-871.
32. Morales, A.; Cowan, J.; Dagua, J.; & Hershberger, R. E. (2008). Family history: an essential tool for cardiovascular genetic medicine. Congestive Heart Failure, 14(1), 37-45.
33. Morales, A.; Painter, T.; Li, R.; Siegfried, J. D.; Li, D.; Norton, N.; et al. (2010a). Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation, 121(20), 2176-2182.
34. Morales, A.; Pinto, J. R.; Siegfried, J.; Li, D.; Norton, N.; Hofmeyer, M.; et al. (2010b). Late onset sporadic dilated cardiomyopathy caused by a cardiac troponin T mutation. Clinical and Translational Science, 3(5), 219-226.
35. Murphy, J.; Scott, J.; Kaufman, D.; Geller, G.; LeRoy, L.; & Hudson, K. (2008). Public expectations for return of results from large-cohort genetic research. The American Journal of Bioethics, 8(11), 36-43.
36. Norton, N.; Li, D.; Reider, M. J.; Siegfried, J. D.; Rampersaud, E.; Zuchner, S.; et al. (2011). Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. American Journal of Human Genetics, 88, 273-282.
37. Parks, S. B.; Kushner, J. D.; Nauman, D.; Burgess, D.; Ludwigsen, S.; Peterson, A.; et al. (2008). Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. American Heart Journal, 156(1), 161-169.
38. Richards, C. S.; Bale, S.; Bellissimo, D. B.; Das, S.; Grody, W. W.; Hegde, M. R.; et al. (2008). ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007. Genetics in Medicine, 10(4), 294-300.
39. Rope, A. F.; Wang, K.; Evjenth, R.; Xing, J.; Johnston, J. J.; Swensen, J. J.; et al. (2011). Using VAAST to identify an X-linked disorder resulting in lethality in male infants due to N-terminal acetyltransferase deficiency. American Journal of Human Genetics, 89(1), 28-43.
40. Trinidad, S. B.; Fullerton, S. M.; Ludman, E. J.; Jarvik, G. P.; Larson, E. B.; & Burke, W. (2011). Research ethics. Research practice and participant preferences: the growing gulf. Science, 331(6015), 287-288.